Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Sever Pharma Solutions AB
AB
Active
Org 5564995081
Agneslundsvägen 27, 212 15
Malmö
Manufacture of pharmaceutical preparations
·
NACE 2120
Est. 1994 · 31 years old
306 employees
Monitor
Share
Sweden
/
Companies
/
Manufacture of pharmaceutical preparations
/
Sever Pharma Solutions AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
205M
409M
614M
819M
440M
2020
478M
2021
610M
2022
634M
2023
712M
2024
EBITDA
SEK millions
119M
89M
59M
30M
0M
37M
2020
49M
+32%
2021
45M
-8%
2022
8M
-82%
2023
95M
+1088%
2024
Income statement
SEK thousands
Item
2020
2021
2022
2023
2024
Revenue
440 421
477 861
609 905
633 791
712 158
Staff expenses
—
—
—
—
—
EBITDA
37 093
48 810
44 658
8 160
95 152
Depreciation & amort.
−16 218
−16 846
−22 010
−26 304
−24 600
EBIT
20 875
31 964
22 648
−18 144
70 552
Net financials
2 497
−4 965
−8 572
−5 408
234
Profit before tax
16 793
16 510
14 955
3 392
41 488
Tax
−3 813
−3 697
−2 644
−2 547
−9 187
Net profit
12 980
12 813
12 311
845
32 301
Balance sheet
SEK thousands
Item
2020
2021
2022
2023
2024
Total assets
429 870
455 704
546 972
637 026
701 833
Equity
159 137
171 950
273 490
366 015
398 316
Long-term debt
131 656
111 020
0
0
34 300
Short-term debt
72 314
94 271
193 734
217 313
185 434
Total debt
203 970
205 291
193 734
217 313
219 734
Financial ratios
5-year trend
EBITDA margin
13.4%
This company
15.8%
Market median
-15% vs market
2020
2024
Equity ratio
56.8%
This company
38.2%
Market median
+49% vs market
2020
2024
Return on equity
8.1%
This company
18.4%
Market median
-56% vs market
2020
2024
Net profit margin
4.5%
This company
8.1%
Market median
-44% vs market
2020
2024
Asset turnover
1.01×
This company
1.12×
Market median
+10% vs market
2020
2024
Debt / equity
0.76×
This company
0.62×
Market median
+23% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
View
PDF
More on Sever Pharma Solutions AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
